USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Syntro Corp.
Address:
10655 Sorrento Valley Rd
San Diego, CA 92121
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
75
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $349,504.00 7
SBIR Phase II $1,635,655.00 4

Award List:

BIOLOGICALLY PRODUCED MACRO-MOLECULES FOR AVIATION MATERIAL

Award Year / Program / Phase:
1983 / SBIR / Phase I
Award Amount:
$49,980.00
Agency / Branch:
DOD / NAVY
Principal Investigator:
Abstract:
N/a

BIOLOGICALLY PRODUCED MACRO-MOLECULES FOR AVIATION MATERIAL

Award Year / Program / Phase:
1985 / SBIR / Phase II
Award Amount:
$500,000.00
Agency / Branch:
DOD / NAVY
Principal Investigator:
Abstract:
Syntro corp has developed the means of constructing artificial genes, and for the expression of these genes as macro-molecules in bacteria. the corporation proposes to perfect this technology and use it for the inexpensive, large-scale production of a polymer suitable for forming fibers films with… More

HUMAN CYTOMEGALOVIRUS (HCMV) IS A SIGNIFICANT HUMAN PATHOGEN.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$49,875.00
Agency:
HHS
Principal Investigator:
Richard d. macdonald , PRINCIPAL INVESTIGATOR
Abstract:
Human cytomegalovirus (hcmv) is a significant human pathogen. while hcmv infection does not produce disease in the majority of cases, major problems may develop from congenital infections or in immunocompromised individuals. it is estimated that the cost of vaccine preventable hcmv disease is… More

HUMAN T-CELL LYMPHOTROPIC VIRUS-III (HTLV-III) IS ALMOST CERTAINLY THE CAUSAL AGENT OF THE EPIDEMIC HUMAN DISEASE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS).

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Richard d macdonald , PRINCIPAL INVESTIGATOR
Abstract:
Human t-cell lymphotropic virus-iii (htlv-iii) is almost certainly the causal agent of the epidemic human disease acquired immunodeficiency syndrome (aids). aids is a major health problem in the u.s.; an effective means of preventingthe spread of the disease would be of great value. this proposal… More

EXPRESSION OF MALARIA CSP ANTIGEN IN RECOMBINANT HERPESVIRUS

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$49,950.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Dr Richard D Macdonald
Abstract:
N/a

ALTERNATIVE SOURCE FOR METAL CHELATION COMPOUNDS

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$49,707.00
Agency:
DOE
Principal Investigator:
Dr. Richard W. Armentrout , Principal Investigator
Abstract:
N/a

ALTERNATIVE SOURCE FOR METAL CHELATION COMPOUNDS

Award Year / Program / Phase:
1987 / SBIR / Phase II
Award Amount:
$485,655.00
Agency:
DOE
Principal Investigator:
Dr. Richard W. Armentrout , Principal Investigator
Abstract:
There is a need for chemicals with a high metal binding capacity which also allows for recovery of the metals in a concentrated form. this chemical should permit repeated recycling, function at low metal concentrations, and be costcompetitive with existing resins. ideally, this agent wouldbe… More

IMPROVED REAGENTS FOR SYPHILIS DIAGNOSIS

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Alan walfield
Abstract:
A project to develop a state-of-the-art serodiagnostic assay for syphilis with recombinant treponema pallidum antigens is proposed. the development of recombinant dna-derived reagents would be of great benefit to the publichealth agencies, clinical labs, hospital, and blood banks that conduct… More

VACCINE FOR INFECTIOUS BURSAL DISEASE VIRUS

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$49,992.00
Agency:
USDA
Principal Investigator:
Dr Thomas J Pollock
Abstract:
N/a

EXPRESSION OF MALARIA CSP ANTIGEN IN RECOMBINANT HERPESVIRUS

Award Year / Program / Phase:
1988 / SBIR / Phase II
Award Amount:
$500,000.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Dr Richard D Macdonald
Abstract:
Malaria is one of the most important parasitic diseases of man. it is caused by species of the protozoan plasmodium which have a complex life cycle of several developmental stages that occur in both man and the insect vector anopheline mosquito. recently, several plasmodium genes have been cloned… More

VACCINE FOR INFECTIOUS BURSAL DISEASE VIRUS

Award Year / Program / Phase:
1988 / SBIR / Phase II
Award Amount:
$150,000.00
Agency:
USDA
Principal Investigator:
Dr Thomas J Pollock
Abstract:
The immunodominant antigen of infectious bursal disease virus has been shown to be a 32 kd structural protein. monoclonal antibody, directed against the protein, passively protects chicks. syntro has cloned the entire large genomic rna segment which codes for a single large polyprotein that is… More